Treatment of the antiphospholipid antibody syndrome |
| |
Authors: | Christopher Wu Kenneth Kalunian |
| |
Affiliation: | (1) Center for Innovative Therapy, UCSD School of Medicine, 9500 Gilman Drive, 92093-0943 La Jolla, CA, USA |
| |
Abstract: | Numerous questions exist regarding the proper management of patients with the antiphospholipid antibody syndrome (APS). Several
recent, randomized-controlled trials have been conducted that attempt to answer the fundamental questions of whom to treat,
how to treat, and for how long treatment should last. These studies suggest that APS should be categorized by disease manifestations,
and these presentations may have different treatment algorithms. A better understanding of the immune mechanisms that govern
thrombosis in this syndrome has led to a wide array of innovative treatment approaches that will require meticulous study. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|